- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
2.Designation of the competent authority and scope of the Regulations
10.Requirement for hospital blood banks to provide information to the Secretary of State
13.Import of blood and blood components into the United Kingdom
14.Disclosure of information by blood establishments and hospital blood banks
PART 2 INFORMATION REQUIREMENTS FOR DONORS
Part A – Information to be provided to prospective donors of blood or blood components
1.Part A – Information to be provided to prospective donors of blood or blood components
2.For both allogeneic and autologous donations, the reasons for requiring...
3.For allogeneic donations, the criteria for self-deferral, and temporary and...
4.For autologous donations, the possibility of deferral and the reasons...
5.Information on the protection of personal data, including confirmation that...
6.The reasons why individuals are not to make donations which...
7.Specific information on the nature of the procedures involved either...
8.Information on the option for donors to change their mind...
10.Information on the responsibility of the blood establishment to inform...
11.Information as to why unused autologous blood and blood components...
12.Information that test results detecting markers for viruses, such as...
13.Information on the opportunity for donors to ask questions at...
Part B – Information to be obtained from donors by blood establishments at every donation
PART 3 ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS
1.Acceptance criteria for donors of whole blood and blood components
1.2.Haemoglobin levels in donor’s blood Haemoglobin For females ≥ 125...
1.4.Platelet levels in donor’s blood Platelets Platelet number greater than...
Deferral criteria for donors of whole blood and blood components
2.1.Deferral criteria for donors of whole blood and blood components
2.2.Temporary deferral criteria for donors of allogeneic donations
2.2.3.Vaccination Attenuated viruses or bacteria 4 weeks Inactivated/killed viruses, bacteria...
2.2.4.Other temporary deferrals Pregnancy 6 months after delivery or termination,...
2.3.Deferral for particular epidemiological situations Particular epidemiological situations (e.g. disease...
2.4.Deferral criteria for donors of autologous donations Serious cardiac disease...
PART 4 STORAGE, TRANSPORT AND DISTRIBUTION CONDITIONS FOR BLOOD AND BLOOD COMPONENTS
1.1.Liquid storage Component Temperature of storage Maximum storage time Red...
1.2.Cryopreservation Component Storage conditions and duration Red blood cells Up...
3.1.Autologous blood and blood components must be clearly identified as...
3.2.Autologous blood and blood components must be labelled as required...
PART 5 QUALITY AND SAFETY REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
1.THE BLOOD COMPONENTS 1. Red cell preparations The components listed...
2.QUALITY CONTROL REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS
2.1.Blood and blood components must comply with the following technical...
2.2.Appropriate bacteriological control of the collection and manufacturing process must...
2.3.For autologous donations, the measures marked with an asterisk (*)...
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including:
The data on this page is available in the alternative data formats listed: